Co-Diagnostics Shares Outstanding 2017-2025 | CODX

Co-Diagnostics shares outstanding from 2017 to 2025. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
Co-Diagnostics Annual Shares Outstanding
(Millions of Shares)
2024 30
2023 29
2022 31
2021 30
2020 28
2019 17
2018 12
2017 11
2016 10
Co-Diagnostics Quarterly Shares Outstanding
(Millions of Shares)
2025-03-31 32
2024-12-31 30
2024-09-30 30
2024-06-30 30
2024-03-31 30
2023-12-31 29
2023-09-30 29
2023-06-30 29
2023-03-31 29
2022-12-31 31
2022-09-30 31
2022-06-30 32
2022-03-31 35
2021-12-31 30
2021-09-30 30
2021-06-30 30
2021-03-31 30
2020-12-31 28
2020-09-30 30
2020-06-30 29
2020-03-31 23
2019-12-31 17
2019-09-30 17
2019-06-30 17
2019-03-31 16
2018-12-31 12
2018-09-30 12
2018-06-30 12
2018-03-31 12
2017-12-31 11
2017-09-30 12
2017-06-30 10
2017-03-31 10
2016-12-31
2016-09-30 10
2016-06-30 10
Sector Industry Market Cap Revenue
Medical Medical Services $0.009B $0.004B
Co-Diagnostics Inc. is a molecular diagnostics company. It develops, manufactures and markets a new, state-of-the-art diagnostics technology. The Company's technology is utilized for tests which are designed using the detection and/or analysis of nucleic acid molecules. It also uses proprietary technology to design specific tests to locate genetic markers for use in industries other than infectious disease and license the use of those tests to specific customers. Co-Diagnostics Inc. is based in UT, United States.
Stock Name Country Market Cap PE Ratio
Danaher (DHR) United States $142.869B 26.80
CVS Health (CVS) United States $84.351B 10.48
Elevance Health (ELV) United States $78.372B 10.11
Cencora (COR) United States $58.632B 20.40
DiDi Global (DIDIY) China $23.485B 24.95
Natera (NTRA) United States $21.669B 0.00
Labcorp Holdings (LH) United States $21.584B 17.51
BioMerieux (BMXMF) France $16.861B 0.00
EUROFINS SCIENT (ERFSF) Luxembourg $13.511B 0.00
Solventum (SOLV) United States $13.191B 13.96
CochLear (CHEOY) Australia $12.755B 0.00
ICON (ICLR) Ireland $11.919B 11.08
Revvity (RVTY) United States $11.635B 20.02
Viatris (VTRS) United States $10.798B 3.71
Avantor (AVTR) United States $9.206B 13.38
Medpace Holdings (MEDP) United States $9.166B 24.34
HealthEquity (HQY) United States $8.806B 38.57
Sonic Healthcare (SKHHY) Australia $8.474B 0.00
Charles River Laboratories (CRL) United States $7.559B 14.81
Caris Life Sciences,�Inc (CAI) United States $6.749B 0.00
Amplifon S.p.A (AMFPF) Italy $5.378B 29.44
Bausch + Lomb (BLCO) Canada $4.885B 28.77
BrightSpring Health Services (BTSG) United States $3.868B 35.48
Sotera Health (SHC) United States $3.236B 18.39
Surgery Partners (SGRY) United States $2.823B 36.72
Concentras Parent (CON) United States $2.608B 15.07
Alignment Healthcare (ALHC) United States $2.600B 0.00
Organon (OGN) United States $2.527B 2.69
GeneDx Holdings (WGS) United States $2.446B 94.22
Ardent Health (ARDT) United States $1.902B 8.11
PACS (PACS) United States $1.902B 0.00
Progyny (PGNY) United States $1.839B 40.47
Premier (PINC) United States $1.812B 13.75
GoodRx Holdings (GDRX) United States $1.693B 33.86
Teladoc Health (TDOC) United States $1.416B 0.00
Establishment Labs Holdings (ESTA) $1.333B 0.00
Pediatrix Medical (MD) United States $1.155B 8.79
CareDx (CDNA) United States $1.027B 16.04
Ryman Healthcare (RYHTY) New Zealand $0.970B 0.00
Agilon Health (AGL) United States $0.965B 0.00
AMN Healthcare Services Inc (AMN) United States $0.813B 7.61
QDM (QDMI) Hong Kong, SAR China $0.729B 0.00
Nutex Health (NUTX) United States $0.698B 10.57
Embecta (EMBC) United States $0.586B 3.95
InnovAge Holding (INNV) United States $0.563B 0.00
LifeMD (LFMD) United States $0.554B 0.00
Omada Health (OMDA) $0.481B 0.00
SBC Medicals (SBC) United States $0.467B 0.00
Sonida Senior Living (SNDA) United States $0.466B 0.00
Auna S.A (AUNA) Luxembourg $0.464B 10.45
So-Young (SY) China $0.436B 0.00
Enhabit (EHAB) United States $0.371B 30.50
Performant Healthcare (PHLT) United States $0.329B 0.00
COMPASS Pathways (CMPS) United Kingdom $0.310B 0.00
Beauty Health (SKIN) United States $0.277B 0.00
Oncology Institute (TOI) United States $0.228B 0.00
DocGo (DCGO) United States $0.155B 25.33
Pheton Holdings (PTHL) China $0.129B 0.00
Sera Prognostics (SERA) United States $0.091B 0.00
KindlyMD (NAKA) United States $0.073B 0.00
Ascend Wellness Holdings (AAWH) United States $0.065B 0.00
IceCure Medical (ICCM) Israel $0.062B 0.00
NeueHealth (NEUE) United States $0.061B 0.00
OpGen (OPGN) United States $0.051B 0.00
ModivCare (MODV) United States $0.047B 0.00
Biodesix (BDSX) United States $0.040B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.036B 0.00
Basel Medical Group (BMGL) Singapore $0.035B 0.00
OSR Holdings (OSRH) United States $0.026B 0.00
Intelligent Bio Solutions (INBS) United States $0.012B 0.00
BioNexus Gene Lab (BGLC) $0.011B 0.00
SeaStar Medical Holding (ICU) United States $0.006B 0.00
XWELL (XWEL) United States $0.005B 0.00
Aclarion (ACON) United States $0.005B 0.00
NewGenIvf Group (NIVF) Thailand $0.004B 0.00
ISpecimen (ISPC) United States $0.002B 0.00
INVO Fertility (IVF) United States $0.002B 0.00
Cano Health (CANOQ) United States $0.000B 0.00